参考文献/References:
[1] Deng B,Tan QY,Fan XQ,et al.Clinical value of assaying tumor supplied group of factor/tumor specific growth factor in patients with solitary pulmonary nodule[J].Clinical Lung Cancer,2011,12(3):192-196.
[2] Hu Y,Wang JL,Tao HT,et al.Expression and significance of TSGF,CEA and AFP in patients before and after radical surgery for colon cancer[J].AsianPacific Journal of Cancer Prevention,2013,14(6):3877-3880.
[3] Wang P,Zhu J,Xie XL,et al.Effects on the tumor specific growth factorand tumor necrosis factor alpha in rats' precancerous lesion of primary hepatocellular carcinoma by direct moxibustion at Ganshu(BL 18)acupoint[J].ChineseJournal of Integrative Medicine,2016,22(7):532-536.
[4] Park JH,Choi H,Kim YB,et al.Serum angiopoietin-1 as a prognostic marker in resected early stage lung cancer[J].Lung Cancer,2009,66(3):359-364.
[5] Hata K,Nakayama K,Fujiwaki R,et al.Expression of the angopoietin-1,angopoietin-2,Tie2,and vascular endothelial growth factor gene in epithelialovarian cancer[J].Gynecologic Oncology,2004,93(1):215-222.
[6] Jiang JT,Wu CP,Deng HF,et al.Serum level of TSGF,CA242 and CA19-9 in pancreatic cancer[J].World J Gastroenterol,2004,10(11):1675-1677.
[7] Chen Y,Gao SG,Chen JM,et al.Serum CA242,CA199,CA125,CEA,and TSGF are biomarkers for the efficacy and prognosis of cryoablation in pancreatic cancer patients[J].Cell Biochemistry and Biophysics,2015,71(3):1287-1291.
[8] Zhou G,Niu L,Chiu D,et al.Changes in the expression of serum markers CA242,CA199,CA125,CEA,TNF-alpha and TSGF after cryosurgery in pancreatic
cancer patients[J].Biotechnology Letters,2012,34(7):1235-1241.
[9] Wong MP,Chan SY,Fu KH,et al.The angiopoietins,Tie2 and vascular endothelial growth factor are differentially expressedin the transformation of normal lung to non-small cell lungcarcinomas[J].Lung Cancer,2000,29(1):11-22.
[10] 唐学静,刘日旭,王亚男.3种标记物的检测在卵巢癌诊断中的临床意义[J].大连医科大学学报,2005,27(1):52-53,66.
Tang XJ,Liu RX,Wang YN.Clinical significance of combined detection of CA125,TSGF and FER in diagnosis of ovarian cancer[J].Journal of Dalian Medical University,2005,27(1):52-53,66.
[11] Yu B,Xu PZ,Wang QW,et al.Clinical value of tu-mour specific growthfactor(TSGF)and carbohydrate antigen-125(CA-125)in carcinoma of the endometrium[J].J Int Med Res,2009,37(3):878-883.
[12] Yin LK,Sun XQ,Mou DZ.Value of combined detection of serum CEA,CA72-4,CA19-9 and TSGF in the diagnosis of gastric cancer[J].Asian Pacific Journal of Cancer Prevention,2015,16(9):3867-3870.
[13] Carter WB,Ward MD.HER-2 regulatory control of angiopoietin-2 in breast cancer[J].Surgery,2000,128(2):153-158.
[14] Wang G,Qin Y,Zhang J,et al.Nipple discharge of CA15-3,CA125,CEA and TSGF as a new biomarker panel for breast cancer[J].International Journal of Molecular Sciences,2014,15(6):9546-9565.
[15] 杨 菁,王 东.恶性肿瘤相关物质群在大肠癌辅助诊断中的临床价值[J].南方医科大学学报,2007,27(10):1577-1579.
Yang J,Wang D.Clinical value of tumor-associated growth factor detection in the diagnosis of colorectal cancinoma[J].J South Med Univ,2007,27(10):1577-1579.
[16] 周淑燕,卓传尚,柳丽娟,等.PIVKA-Ⅱ和AFP联合检测对原发性肝癌的诊断价值[J].现代检验医学杂志,2017,32(1):69-71,76.
Zhou SY,Zhuo CS,Liu LJ,et al.Clinical value of serum PIVKA-Ⅱ and AFPdetection for primary hepatocellular carcinoma[J].J Mod Lab Med,2017,32(1):69-71,76.
[17] 卓传尚,柳丽娟,周淑燕,等.AFP-L3和PIVKA-Ⅱ检测对高危人群良恶性肝病的鉴别诊断价值[J].现代检验医学杂志,2017,32(4):40-42,46.
Zhuo CS,Liu LJ,Zhou SY,et al.Performance of serum AFP-L3 and PIVKA-Ⅱ in differential diagnosis of benign and malignant liver disease in high riskpopulation[J].J Mod Lab Med,2017,32(4):40-42,46.